Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting.
AffiliationChristie Hospital and Holt Radium Institute, Withington, Manchester, U.K.
MetadataShow full item record
AbstractThis randomised, open, parallel group study compared the antiemetic efficacy and tolerability of tropisetron with metoclopramide plus lorazepam in 102 patients receiving a first course of non-cisplatin-containing chemotherapy. Control of acute vomiting by tropisetron was significantly superior to that of the metoclopramide regimen, with total control (no vomiting) in 45% of 51 patients in the tropisetron group compared with 22% of 51 patients in the metoclopramide group (P = 0.013); total and partial control (< 5 vomits) occurred in 67 and 47% of patients, respectively (P = 0.044). The incidences of acute nausea and of delayed nausea and emesis were similar in the two treatment groups. Both tropisetron and metoclopramide were well tolerated; no adverse effects were attributed to tropisetron administration with the exception of headache. One patient in the metoclopramide group reported confusion and tremor thought to be related to the antiemetic therapy. Tropisetron is an effective and well-tolerated agent in the prevention of chemotherapy-induced vomiting. The control of acute nausea was similar in the two treatment groups, but tropisetron was superior to a metoclopramide-based regimen in the control of acute vomiting.
CitationTropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting. 1994, 30A (5):610-5 Eur. J. Cancer
JournalEuropean Journal of Cancer
- Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
- Authors: Sorbe BG
- Issue date: 1994 Oct
- Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
- Authors: Chang TC, Hsieh F, Lai CH, Tseng CJ, Cheng HH, Li CL, Michael BJ, Soong YK
- Issue date: 1996
- Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
- Authors: Bruntsch U, Drechsler S, Eggert J, Gosse H, Ukena D, Imhoff W, Faerber L
- Issue date: 1994 Oct
- Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
- Authors: Malik I, Moid I, Khan Z, Hussain M
- Issue date: 1999 Apr
- A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
- Authors: Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen BT, Räisänen I, van Oosterom AT, de Bruijn KM
- Issue date: 1994 Jan 15